Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
TMDX
#1482
TransMedics Group, Inc. Common Stock
115.6
8
USD
+2.05%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+2.05%
Changement Mensuel
-7.46%
Evolution sur 6 mois
+3.29%
Changement Annuel
+33.75%
Clôture Précédente
113.3
6
Open
115.6
8
Bid
Ask
Low
115.6
8
High
115.6
8
Volume
102
Marchés
Actions des Marchés US
Soins de Santé
TMDX
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
27.18 M
27.96 M
32.2 M
32.72 M
33.66 M
34.3 M
—
Valuation ratios
Enterprise value
554.74 M
553.97 M
1.71 B
2.63 B
2.28 B
4.19 B
15.24 B
Price to earnings ratio
—
-11.97
-46.43
-99.74
61.73
24.98
189.31
Price to sales ratio
—
17.49
18.06
10.34
4.97
8.15
30.54
Price to cash flow ratio
—
-18.33
-36.84
-191.69
44.99
25.57
144.18
Price to book ratio
—
7.8
9.01
18.2
9.61
10.42
21.94
Enterprise value to EBITDA ratio
-20.97
-13.56
-58.57
-103.05
30.78
27.14
122.98
Profitability ratios
Return on assets %
-0.19
-0.33
-0.13
-0.04
0.04
0.18
0.19
Return on equity %
-0.28
-0.65
-0.19
-0.18
0.16
0.4
0.5
Return on invested capital %
-671.93
-483.41
-306.8
-66.23
43.32
163.65
163.99
Gross margin %
64.88
69.92
69.84
63.77
59.36
59.92
239.76
Operating margin %
-102.91
-130.29
-33.64
-11.89
8.49
17.93
71.79
EBITDA margin %
-96.75
-124.28
-29.92
-8.5
12.97
22.42
89.75
Net margin %
-112.13
-146.11
-38.77
-10.36
8.03
31.43
122.53
Liquidity ratios
Quick ratio
11.35
4.47
9.79
8.49
7.52
6.59
31.21
Current ratio
12.36
5.11
10.66
9.3
8.3
7.14
33.79
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.2
0.21
0.45
0.49
0.58
0.65
0.67
Solvency ratios
Debt to assets ratio
0.23
0.32
0.24
0.73
0.64
0.48
2.21
Debt to equity ratio
0.33
0.65
0.36
3.76
2.27
1.08
6.07
Long term debt to total assets ratio
0.23
0.26
0.21
0.72
0.63
0.47
2.19
Long term debt to total equity ratio
0.33
0.52
0.31
3.69
2.23
1.06
6.01
Per share metrics
Operating cash flow per share
—
-1.05
-1.55
-0.4
1.39
4.76
4.75
EBIT per share
—
-1.43
-1.06
-0.88
1.06
2.68
2.69
EBITDA per share
—
-1.36
-0.95
-0.63
1.63
3.35
3.36
Total debt per share
—
1.59
2.29
15.87
14.72
12.56
50.74
Cash per share
—
3.35
6.81
12.14
9.56
12.05
41.13
Net current asset value per share
—
4.3
8.54
15.7
14.12
15.73
57.21
Tangible book value per share
—
2.46
6.34
3.78
6.1
11.34
33.56
Working capital per share
—
3.46
7.74
14.01
12.42
13.53
50.26
Book value per share
—
2.46
6.34
4.22
6.49
11.67
34.9
Nouvelles
Oppenheimer réitère sa recommandation sur TransMedics malgré les coûts de carburant
TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound?
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TransMedics à la conférence Oppenheimer : expansion stratégique dévoilée
TransMedics at Oppenheimer Conference: Strategic Expansion Unveiled
TD Cowen réitère sa recommandation d’achat sur TransMedics après l’approbation pour le foie
TD Cowen reiterates TransMedics stock Buy rating on liver approval
TransMedics: Rapidly Scaling Business Nears Free Cash Flow Breakeven (NASDAQ:TMDX)
Le directeur financier de TransMedics Group, Hernandez, vend des actions pour 1,12 million $
TransMedics group CFO Hernandez sells shares worth $1.12 million
TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade) (TMDX)
TransMedics: Numb Reaction To Extraordinary Fundamentals (NASDAQ:TMDX)